| 1 |
35388061 | Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism. | 2022 Apr 6 |
1 |
| 2 |
32999756 | Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. | 2020 |
1 |
| 3 |
30902661 | Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord. | 2019 May |
1 |
| 4 |
24759231 | Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. | 2014 May 30 |
4 |
| 5 |
21417343 | Crystal structures of ABL-related gene (ABL2) in complex with imatinib, tozasertib (VX-680), and a type I inhibitor of the triazole carbothioamide class. | 2011 Apr 14 |
2 |
| 6 |
15032571 | The BCR-ABL story: bench to bedside and back. | 2004 |
2 |